Tradestie Institutional Equity Comparison Engine

FDMT vs STOK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FDMT Overall Edge

FDMT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to 4D Molecular Therapeutics, Inc. Common Stock (FDMT) driven by superior Growth & Margin, Momentum & Technical while STOK counters with relative strength in Options & Structure. Fundamentally, FDMT trades at N/M Forward P/E with -222.7% operating margin (+4505.6% YoY revenue) versus STOK at N/M Forward P/E and -913.2% operating margin (+5.9% YoY). In options structure, FDMT sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against STOK sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
FDMT N/M vs STOK N/M Fwd P/E
Growth & Margin Winner FDMT
Op Margin -222.7% vs -913.2% ยท YoY +4505.6% vs +5.9%
Momentum & Technical Winner FDMT
1Y +13.3% vs +1.8% ยท 52W Pos 47% vs 25%
Options & Structure Winner STOK
BREAKDOWN (10th %ile IV) vs SURGE (8th %ile IV)
FDMT NASDAQ
4D Molecular Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$11.65
-4.74% 1D
Market Cap $669.3M
1M Return -4.04%
1Y Return +13.33%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 21.0 Fund 54.0 Flow 66.0 Mom 54.0
STOK NASDAQ
Stoke Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$26.54
-0.52% 1D
Market Cap $1.7B
1M Return +9.81%
1Y Return +1.8%
Forward P/E N/M
Unified AI Score
55.8 / 100 HOLD
Tech 37.0 Fund 52.0 Flow 64.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FDMT +13.33% STOK +1.8% Spread: +11.53 pp (FDMT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period FDMT Revenue STOK Revenue FDMT Op. Margin STOK Op. Margin Margin Edge
FY2019 $10M N/A -729.4% N/A FDMT
FY2020 $10M N/A -424.0% N/A FDMT
FY2021 $20M N/A -395.5% N/A FDMT
FY2022 $0M $10M -3516.5% -841.2% STOK
FY2023 $20M $10M -544.6% -1307.2% FDMT
FY2024 $0M $40M -507678.4% -277.3% STOK
FY2025 $90M $180M -187.2% -11.2% STOK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FDMT (4) vs STOK (4)
Institutional Metric FDMT STOK Criterion Row Winner
Market Capitalization Scale $669.3M $1.7B Larger Scale STOK
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +4505.6% +5.9% Higher Growth FDMT
Operating Margin (TTM) Profitability -222.7% -913.2% Higher Margin FDMT
Net Profit Margin Profitability -208.6% 0.0% Higher Margin STOK
Return on Equity (ROE) Capital Efficiency -56.7% -73.6% Higher ROE FDMT
52-Week Range Position Momentum 47% ($7โ€“$17) 25% ($22โ€“$40) Stronger Trend FDMT
Beta / 30D Volatility Risk Regime 1.89ฮฒ ยท 90% Vol 0.99ฮฒ ยท 47% Vol Lower Realized Risk STOK
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 55.8 / 100 (HOLD) Higher Composite STOK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FDMT vs STOK Buy Guide
FDMT BREAKDOWN
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live FDMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
STOK SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live STOK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FDMT nor STOK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.